These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2151711)

  • 1. The heart in congestive failure.
    Katz AM
    Cardioscience; 1990 Mar; 1(1):3-6. PubMed ID: 2151711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardiomyopathy of overload: a hypothesis.
    Katz AM
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S68-71. PubMed ID: 1725047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and abnormalities of contractility and relaxation in the failing heart.
    Katz AM
    Cardiologia; 1993 Dec; 38(12 Suppl 1):39-43. PubMed ID: 8020041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of dilated cardiomyopathy with digitalis, diuretics and vasodilators].
    Liebau G
    Herz; 1985 Jun; 10(3):138-42. PubMed ID: 2991095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of the failing heart.
    Katz AM
    Cardioscience; 1993 Dec; 4(4):199-203. PubMed ID: 8298061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cellular and molecular mechanisms in heart failure].
    Krause EG
    Z Kardiol; 1991; 80 Suppl 8():13-8. PubMed ID: 1724587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure.
    Katz AM
    N Engl J Med; 1990 Jan; 322(2):100-10. PubMed ID: 2403651
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy and course of dilated cardiomyopathy].
    Hess OM; Greminger P; Maire R; Turina J; Krayenbühl HP
    Schweiz Med Wochenschr; 1985 May; 115(20):693-7. PubMed ID: 3892658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micromethods for determining activities of energy-producing and non-energy-producing pathways in myocardial tissue.
    King JW; Kennedy FS; Hanley HG; Lierl JJ; Fowler MR; White MC
    Am J Pathol; 1986 May; 123(2):310-7. PubMed ID: 3706492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
    Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
    J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to beta-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy].
    Shinke T; Takaoka H; Takeuchi M; Hata K; Kawai H; Okubo H; Kijima Y; Murata T; Yokoyama M
    J Cardiol; 2001 Feb; 37(2):119-20. PubMed ID: 11255696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognized molecular mechanisms of heart failure: approaches to treatment.
    Ceconi C; Cargnoni A; Curello S; Ferrari R
    Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II79-91. PubMed ID: 9835784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in gene expression in terminal myocardial failure].
    Eschenhagen T; Mende U; Schmitz W; Scholz H
    Z Kardiol; 1992; 81 Suppl 4():33-40. PubMed ID: 1290304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy requirements of contraction and relaxation: implications for inotropic stimulation of the failing heart.
    Katz AM
    Basic Res Cardiol; 1989; 84 Suppl 1():47-53. PubMed ID: 2530976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From overload to failure: what happens inside the myocyte.
    Harding SE; Davia K; Davies CH; del Monte F; Money-Kyrle AR; Poole-Wilson PA
    Ann Med; 1998 Aug; 30 Suppl 1():14-23. PubMed ID: 9800879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
    Harinstein ME; Berliner JI; Shah SJ; Taegtmeyer H; Gheorghiade M
    Am J Ther; 2008; 15(3):206-13. PubMed ID: 18496257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure.
    Morgan JP; Erny RE; Allen PD; Grossman W; Gwathmey JK
    Circulation; 1990 Feb; 81(2 Suppl):III21-32. PubMed ID: 2153479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is heart failure an abnormality of myocardial cell growth?
    Katz AM
    Cardiology; 1990; 77(5):346-56. PubMed ID: 2073654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.